Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare
Biomarin Pharmaceutical Inc. Total Liabilities 2008–2025
Biomarin Pharmaceutical Inc. annual total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Biomarin Pharmaceutical Inc. total liabilities as of December 31, 2025: 1.51B, a 13.23% increase year-over-year.
- Biomarin Pharmaceutical Inc. total liabilities for 2025 were 1.51B, a 13.23% increase from 2024.
- Biomarin Pharmaceutical Inc. total liabilities for 2024 were 1.33B, a 29.58% decrease from 2023.
- Biomarin Pharmaceutical Inc. total liabilities for 2023 were 1.89B, a 6.67% increase from 2022.
- Biomarin Pharmaceutical Inc. total liabilities for 2022 were 1.77B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Biomarin Pharmaceutical Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1,507 |
| 2024 | $1,331 |
| 2023 | $1,890 |
| 2022 | $1,772 |
| 2021 | $1,739 |
| 2020 | $1,742 |
| 2019 | $1,568 |
| 2018 | $1,459 |
| 2017 | $1,824 |
| 2016 | $1,257 |
| 2015 | $1,329 |
| 2014 | $947 |
| 2013 | $903 |
| 2012 | $553 |
| 2011 | $533 |
Biomarin Pharmaceutical Inc. Total Liabilities — FAQ
Biomarin Pharmaceutical Inc. (BMRN) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMRN's total liabilities history?
The chart and table above show Biomarin Pharmaceutical Inc.'s total liabilities by year and by quarter, including the growth rate.